819TiP COLIBRI trial (GINECO-CE108b): A multicenter, window study evaluating immune impact and safety of nivolumab in combination with ipilimumab before initial radio-chemotherapy (RTCT) treatment for locally advanced cervix cancer.
Saved in:
| Title: | 819TiP COLIBRI trial (GINECO-CE108b): A multicenter, window study evaluating immune impact and safety of nivolumab in combination with ipilimumab before initial radio-chemotherapy (RTCT) treatment for locally advanced cervix cancer. |
|---|---|
| Authors: | Ray-Coquard, I.L.1 (AUTHOR), Kaminsky-Forrett, M-C.2 (AUTHOR), Joly, F.3 (AUTHOR), Montané, L.4 (AUTHOR), Bello Roufai, D.5 (AUTHOR), Savoye, A.M.6 (AUTHOR), Angelergues, A.7 (AUTHOR), Hardy-Bessard, A-C.8 (AUTHOR), Mouret Reynier, M.A.9 (AUTHOR), Deluche, E.10 (AUTHOR), Caux, C.11 (AUTHOR), Saintigny, P.12 (AUTHOR), Péré, H.13 (AUTHOR), Treilleux, I.14 (AUTHOR), Betrian, S.15 (AUTHOR), Lecuru, F.16 (AUTHOR) |
| Source: | Annals of Oncology. 2021 Supplement 5, Vol. 32, pS770-S770. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152689475 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 819TiP COLIBRI trial (GINECO-CE108b): A multicenter, window study evaluating immune impact and safety of nivolumab in combination with ipilimumab before initial radio-chemotherapy (RTCT) treatment for locally advanced cervix cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ray-Coquard%2C+I%2EL%2E%22">Ray-Coquard, I.L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kaminsky-Forrett%2C+M-C%2E%22">Kaminsky-Forrett, M-C.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Joly%2C+F%2E%22">Joly, F.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Montané%2C+L%2E%22">Montané, L.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bello+Roufai%2C+D%2E%22">Bello Roufai, D.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Savoye%2C+A%2EM%2E%22">Savoye, A.M.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Angelergues%2C+A%2E%22">Angelergues, A.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hardy-Bessard%2C+A-C%2E%22">Hardy-Bessard, A-C.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mouret+Reynier%2C+M%2EA%2E%22">Mouret Reynier, M.A.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Deluche%2C+E%2E%22">Deluche, E.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Caux%2C+C%2E%22">Caux, C.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saintigny%2C+P%2E%22">Saintigny, P.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Péré%2C+H%2E%22">Péré, H.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Treilleux%2C+I%2E%22">Treilleux, I.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Betrian%2C+S%2E%22">Betrian, S.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lecuru%2C+F%2E%22">Lecuru, F.</searchLink><relatesTo>16</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2021 Supplement 5, Vol. 32, pS770-S770. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152689475 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2021.08.1261 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S770 Titles: – TitleFull: 819TiP COLIBRI trial (GINECO-CE108b): A multicenter, window study evaluating immune impact and safety of nivolumab in combination with ipilimumab before initial radio-chemotherapy (RTCT) treatment for locally advanced cervix cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ray-Coquard, I.L. – PersonEntity: Name: NameFull: Kaminsky-Forrett, M-C. – PersonEntity: Name: NameFull: Joly, F. – PersonEntity: Name: NameFull: Montané, L. – PersonEntity: Name: NameFull: Bello Roufai, D. – PersonEntity: Name: NameFull: Savoye, A.M. – PersonEntity: Name: NameFull: Angelergues, A. – PersonEntity: Name: NameFull: Hardy-Bessard, A-C. – PersonEntity: Name: NameFull: Mouret Reynier, M.A. – PersonEntity: Name: NameFull: Deluche, E. – PersonEntity: Name: NameFull: Caux, C. – PersonEntity: Name: NameFull: Saintigny, P. – PersonEntity: Name: NameFull: Péré, H. – PersonEntity: Name: NameFull: Treilleux, I. – PersonEntity: Name: NameFull: Betrian, S. – PersonEntity: Name: NameFull: Lecuru, F. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2021 Supplement 5 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 32 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |